37 min listen
Long-term outcome in neuroZika: When biological diagnosis matters
Long-term outcome in neuroZika: When biological diagnosis matters
ratings:
Length:
19 minutes
Released:
May 20, 2019
Format:
Podcast episode
Description
In the first segment, Dr. Stacey Clardy talks with Dr. Annie Lannuzel about the importance of biological diagnosis in long-term outcome in neuroZika. In the second part of the podcast, Dr. Will Rondeau focuses his interview with Dr. Stuart Connolly on his NEJM paper on the full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. The paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa1814051. CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
Released:
May 20, 2019
Format:
Podcast episode
Titles in the series (100)
September 4 2007 Issue: Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. by Neurology® Podcast